What is WALD's current stock price?

WALD (Waldencast plc) is currently trading at $1.30 with a market cap of $153.7M.

What sector is Waldencast plc in?

Waldencast plc (WALD) operates in the Technology sector, specifically in the Software - Application industry.

Is WALD a good stock to buy?

Analysts have a Hold consensus on WALD with a price target of $2.00. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

WALD Waldencast plc

Technology

$1.30+0.00%ClosedMarket Cap: $153.7M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

0.33

P/S

0.56

EV/EBITDA

-1.77

DCF Value

$-7.83

FCF Yield

-10.6%

Div Yield

0.0%

Margins & Returns

Gross Margin

45.5%

Operating Margin

-22.7%

Net Margin

-84.4%

ROE

-47.8%

ROA

-28.1%

ROIC

-7.8%

Financials

View All

Period	Revenue	Net Income	EPS
Q4 null	$139.8M	$-60.3M	$—
FY null	$272.1M	$-229.7M	$—
Q2 null	$132.3M	$-169.4M	$—
Q4 null	$142.3M	$-32.4M	$—

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$2.00

Target (Median)

$2.00

Target Range

$2.00 - $2.00

0 Strong Buy1 Buy3 Hold0 Sell0 Strong Sell

Canaccord GenuityBuy

2026-03-16

Telsey Advisory GroupMarket Perform

2026-03-16

Telsey Advisory GroupMarket Perform

2025-11-25

Canaccord GenuityBuy

2025-11-25

Telsey Advisory GroupOutperform

2025-08-20

Trading Activity

Insider Trades

View All

Thompson Motta Roberto Mosesdirector

SellWed Mar 18

Souza Cristianodirector, 10 percent owner:

SellWed Mar 18

Souza Cristianodirector, 10 percent owner:

SellWed Mar 18

Souza Cristianodirector, 10 percent owner:

SellWed Mar 18

Brousset Micheldirector, officer: Chief Executive Officer

SellWed Mar 18

Company Info

Sector

Technology

Industry

Software - Application

Country

Exchange

—

Beta

-0.10

Waldencast Acquisition Corp. a skin care company, provides advanced skin care treatments. Its products are designed to help minimize the appearance of premature skin aging, skin damage, hyperpigmentation, acne, and sun damage primarily available through dermatologists, plastic surgeons, medical spas, and other skin care professionals. Its portfolio includes Obagi Medical that provides transformational skin care products formulated to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines, and wrinkles and to protect and enhance skin tone and texture; and Obagi Clinical that offers skin care products designed to prevent the early signs of skin aging. The company was founded in 1988 and is based in White Plains, New York.

Peers

MRT